Veliparib (ABT-888) is a PARP inhibitor being investigated to treat non-small cell lung cancer, BRCA breast cancer and ovarian cancer.

Type of Molecule

Small Molecule

Target

PARP

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Breast Cancer New Indication Phase 3
Lung Cancer New Indication Phase 3
Ovarian Cancer New Indication Phase 3